A Journey to the core of Lungs

Novel management for Hemoptysis

Hemoptysis is a common complaint in our daily clinical practice, which needs further investigations. Hemoptysis is defined as the coughing of blood-streaked sputum or gross blood that is originating from the lower respiratory tract. Massive hemoptysis has a mortality rate of >50%. The source of massive hemoptysis is the bronchial circulation in the majority of patients. Bronchial artery embolization (BAE) is considered the most effective non-surgical tool for management of recurrent and/or massive hemoptysis.

Bronchial artery embolization (BAE) is now considered to be the first-line therapy to control chronic recurrent mild and moderate hemoptysis, since its introduction in 1973. Clinical success immediately post-embolization reaches 73–99% of patients.

Register Now